Several biomarkers associated with immunological status have been discovered with variable success, including tumor mutation burden (TMB) [4], specific genetic mutations [5], expression level of PD-L1 [6] and presence of tumor immune infiltrates [7]. The gene discussed is CD274; the disease is neoplasm.